Metal-overlayer-induced charge-transfer effects in thin SiO₂-Si structures

The evolution of core-level photoemission spectra has been studied during the initial stages of Cs and In overlayer growth on thin SiO2 layers on Si(111) substrates to probe the influence of the metal-SiO2 interaction on the charge state of the resulting structure. The Si 2p soft-x-ray photoelectron spectra on the SiO2 and the Si substrate, which have been recorded simultaneously, show substantially different shifts to higher binding energy for the two components of the structure for Cs adsorption on the SiO2 surface, but only small uniform shifts for In overlayers. The Si 2p core-level spectra have been analyzed by simulating the spectra with a model that separates the Cs-covered SiO2 structure into thin layers with a constant dipole field gradient applied across them. Accordingly, the metal-induced Si 2p core-level shifts of the Si substrate are interpreted in terms of Si band-bending changes as a result of charge transport from the metal layer to the SiO2/Si interface. The differential Si 2p shifts, which lead to a larger separation of substrate and oxide peaks on cesiated SiO2/Si than on the pristine SiO2/Si structure, are discussed in terms of a Cs-induced dipole field across the SiO2 layer. It is proposed that the different behavior of Cs and In overlayers may be related to the different electronegativity and, consequently, to the different adsorbate dipoles of the two metals

Symmetrical Dimethylarginine as a Diagnostic Parameter in Hermann's Tortoises (Testudo hermanni)

BackgroundDespite improvements in habitational conditions, kidney disease is relatively common in tortoises. ObjectivesPurpose of this study was the establishment of Symmetrical dimethylarginine (SDMA) reference values for clinically healthy Hermann's Tortoises. AnimalsClinically healthy Hermann's Tortoises (n = 131) were included in the period from October 2017 to September 2019. MethodsCreatinine and other biomarkers were tested at IDEXX Laboratories, Germany using residual blood samples from Hermann's tortoises. SDMA was measured with the IDEXX test and verified by liquid chromatography-mass spectrometry at IDEXX Laboratories, USA. ResultsSDMA values ranged from 1 to 21 mu g/dl (n = 131) for the IDEXX SDMA Test and SDMA values ranged from 1 to 17 mu g/dl (n = 82) for LC-MS. For the comparison of the two measuring systems, the following results were obtained R-2 = 0.75 (p < 0.001). Conclusion and Clinical ImportanceSDMA can be measured in Hermann's Tortoises and the reference values range in clinically healthy animals is comparable to that of dogs and cats

Recovery of molybdenum, chromium, tungsten, copper, silver, and zinc from industrial waste waters using zero-valent iron and tailored beneficiation processes

Zero-valent iron (ZVI) has been used for water treatment for more than 160 years. However, passivation of its surface often constituted a problem which could only be tackled recently by the innovative Ferrodecont process using a fluidized bed reactor. In this study, pilot scale experiments for the removal of Mo, Cr, W, Cu, Ag and Zn from two industrial waste water samples and lab-scale experiments for the beneficiation of the abrasion products are presented to integrate the Ferrodecont process into a complete recycling process chain. Firstly, 38.5 % of Cu was removed from sample A, yielding abrasion products containing 33.1 wt% Cu as metallic copper (Cu) and various Cu compounds. The treatment of sample B removed 99.8 % of Mo, yielding abrasion products containing 17.8 wt% of Mo as amorphous phases or adsorbed species. Thermal treatment (1300 &deg;C) of the abrasion product A indicated a reduction of delafossite to metallic Cu according to differential scanning calorimetry (DSC), thermogravimetry (TG) and X-ray diffraction (XRD), which was successfully separated from the magnetic iron phases. Hydrometallurgical treatment (1.5 M NaOH, 3 d, liquid:solid ratio (L:S) = 15:1) of sample B yielded aqueous extracts with Mo concentrations of 5820 to 6300 mgL&minus;1. In conclusion, this corresponds to an up to 53-fold enrichment of Mo during the entire process chain

Reassessment of Relevance and Predictive Value of Parameters Indicating Early Graft Dysfunction in Liver Transplantation: AST Is a Weak, but Bilirubin and INR Strong Predictors of Mortality

Introduction: Early graft dysfunction (EAD) complicates liver transplantation (LT). The aim of this analysis was to discriminate between the weight of each variable as for its predictive value toward patient and graft survival. Methods: We reviewed all LT performed at the Medical University of Innsbruck between 2007 and 2018. EAD was recorded when one of the following criteria was present: (i) aspartate aminotransferase (AST) levels >2,000 IU/L within the first 7 days, (ii) bilirubin levels 10mg/dL or (iii) international normalized ratio (INR) 1.6 on postoperative day 7. Results: Of 616 LT, 30.7% developed EAD. Patient survival did not differ significantly (P = 0.092; log rank-test = 2.87), graft survival was significantly higher in non-EAD patients (P = 0.008; log rank-test = 7.13). Bilirubin and INR on postoperative day 7 were identified as strong mortality predictors (Bilirubin HR = 1.71 [1.34, 2.16]; INR HR = 2.69 [0.51, 14.31]), in contrast to AST (HR = 0.91 [0.75, 1.10]). Similar results were achieved for graft loss estimation. A comparison with the Model for Early Allograft Function (MEAF) and the Liver Graft Assessment Following Transplantation (L-GrAFT) score identified a superior discrimination potential but lower specificity. Conclusion: Contrarily to AST, bilirubin and INR have strong predictive capacity for patient and graft survival. This fits well with the understanding, that bile duct injury and deprivation of synthetic function rather than hepatocyte injury are key factors in LT

Bariatric surgery prevents carotid wall thickness progression.

BACKGROUND Bariatric surgery is a treatment option for patients with severe obesity and improves parameters of cardiovascular and/or metabolic disease. Carotid intima media thickness (C-IMT) is a surrogate measure of subclinical atherosclerosis. Previous studies showed short to mid-term arrest and even regression of C‑IMT progression following bariatric surgery. We aimed to investigate the long-term effect of weight loss on C‑IMT progression 10 years after bariatric surgery in comparison to a population-based control cohort. METHODS In total, 21 eligible patients were examined preoperatively, at 5 and 10 years after bariatric surgery. Anthropometric parameters, plasma triglycerides, total cholesterol, high-density lipoprotein cholesterol (HDL-C), insulin, and glucose were assessed at all three study visits. C‑IMT was measured via B‑mode scans of the common carotid artery. C‑IMT progression was measured in an age-matched and BMI-matched cohort selected from the population-based Bruneck study to compare with changes in C‑IMT progression after bariatric surgery. RESULTS C‑IMT remained stable over the 10-year observation period after bariatric surgery. The control cohort showed a significant C‑IMT progression over 10 years. The difference in C‑IMT progression over 10 years was significant (p < 0.01) between both cohorts. CONCLUSION Weight loss induced by bariatric surgery halts the natural progression of C‑IMT over a 10-year observation period

E-AHPBA-ESSO-ESSR Innsbruck consensus guidelines for preoperative liver function assessment before hepatectomy

Background Posthepatectomy liver failure (PHLF) contributes significantly to morbidity and mortality after liver surgery. Standardized assessment of preoperative liver function is crucial to identify patients at risk. These European consensus guidelines provide guidance for preoperative patient assessment. Methods A modified Delphi approach was used to achieve consensus. The expert panel consisted of hepatobiliary surgeons, radiologists, nuclear medicine specialists, and hepatologists. The guideline process was supervised by a methodologist and reviewed by a patient representative. A systematic literature search was performed in PubMed/MEDLINE, the Cochrane library, and the WHO International Clinical Trials Registry. Evidence assessment and statement development followed Scottish Intercollegiate Guidelines Network methodology. Results Based on 271 publications covering 4 key areas, 21 statements (at least 85 per cent agreement) were produced (median level of evidence 2− to 2+). Only a few systematic reviews (2++) and one RCT (1+) were identified. Preoperative liver function assessment should be considered before complex resections, and in patients with suspected or known underlying liver disease, or chemotherapy-associated or drug-induced liver injury. Clinical assessment and blood-based scores reflecting liver function or portal hypertension (for example albumin/bilirubin, platelet count) aid in identifying risk of PHLF. Volumetry of the future liver remnant represents the foundation for assessment, and can be combined with indocyanine green clearance or LiMAx® according to local expertise and availability. Functional MRI and liver scintigraphy are alternatives, combining FLR volume and function in one examination. Conclusion These guidelines reflect established methods to assess preoperative liver function and PHLF risk, and have uncovered evidence gaps of interest for future research.publishedVersio

Metallothionein expression correlates with metastatic and proliferative potential in squamous cell carcinoma of the oesophagus

The goal of this study is to clarify whether the expression of metallothionein (MT) could affect the prognosis and the metastatic potential of squamous cell carcinoma (SCC) of the oesophagus. In paraffin-embedded specimens resected from 57 patients, MT mRNA and protein expressions were detected by in situ hybridization and immunohistochemistry respectively. The expression of MT was evaluated in respect of clinicopathologic variables and patients' survival. MT mRNA expression was significantly associated with the proportion of lymph node metastasis (71% in MT mRNA-positive tumours vs 42% in MT mRNA-negative tumours; P = 0.0343) and that of distant metastasis (29% in MT mRNA-positive tumours vs 5% in MT mRNA-negative tumours; P = 0.0452). In respect of MT protein expression, the frequency of distant metastasis was more common in MT-positive tumours than in MT-negative tumours (30% in MT-positive tumours vs 8% in MT-negative tumours; P = 0.0446). The survival rate of the patients with MT protein-negative tumours was significantly better than that of the patients with MT protein-positive tumours (P = 0.0340). There was a positive correlation between the expression of MT protein and that of proliferating cell nuclear antigen (P = 0.0018). Therefore, we conclude that MT expression, both at the mRNA and protein levels, may be a potential marker predicting metastatic and proliferative activities of oesophageal SCC. © 1999 Cancer Research Campaig